Intelligence Platform
Patents
Browse 202 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11530410
Methods for treating hypercholesterolemia
granted patentUS 11525136
Modulators of APOL1 expression
granted patentUS 11492617
Compositions and methods for modulation of protein aggregation
granted patentUS 11447521
Compounds and methods for modulating angiotensinogen expression
granted patentUS 11421231
Modulation of Huntington expression
granted patentUS 11414657
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
granted patentUS 11400161
Method of conjugating oligomeric compounds
granted patentUS 11376273
Modulation of factor 11 expression
granted patentUS 11365416
Modulators of EZH2 expression
granted patentUS 11339393
Compositions for modulating C9ORF72 expression
granted patentUS 11332746
Compounds and methods for reducing LRRK2 expression
granted patentUS 11319536
Modulating apolipoprotein (a) expression
granted patentUS 11312962
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted patentUS 11312964
Compositions and methods for modulating growth hormone receptor expression
granted patentUS 11299737
Compounds and methods for modulating SMN2
granted patentUS 11299736
Conjugated antisense compounds and their use
granted patentUS 11293025
Compositions and methods for modulating Ataxin 3 expression
granted patentUS 11241451
Modulators of IRF4 expression
granted patentUS 11236335
Selective antisense compounds and uses thereof
granted patentUS 11236339
Modulation of GYS1 expression
granted patentUS 11230712
Compounds and methods for reducing SNCA expression
granted patentUS 11225664
Modulation of angiopoietin-like 3 expression
granted patentUS 11214803
Modulators of YAP1 expression
granted patentUS 11208650
Modulators of IRF5 expression
granted